Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss

Association of Plasma Pentraxin 3 With Arterial Stiffness in Overweight and Obese Individuals

(2013) A. Miyaki et al.   AMERICAN JOURNAL OF HYPERTENSION

Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome

(2013) Rocco Barazzoni et al.   Cardiovascular Diabetology

Elevated Circulating Levels and Tissue Expression of Pentraxin 3 in Uremia: A Reflection of Endothelial Dysfunction

(2013) Anna Witasp et al.   PLoS One

Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: Data from the Heart and Soul Study

(2012) Ruth Dubin et al.   AMERICAN HEART JOURNAL

Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity

(2011) O. Osorio-Conles et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Pentraxin 3: A novel and independent prognostic marker in ischemic stroke

(2011) Wi-Sun Ryu et al.   ATHEROSCLEROSIS

Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications

(2011) Paweł CieŚlik et al.   AUTOIMMUNITY

Inverse Relationship between the Inflammatory Marker Pentraxin-3, Fat Body Mass, and Abdominal Obesity in End-Stage Renal Disease

(2011) T. Miyamoto et al.   Clinical Journal of the American Society of Nephrology

Is Pentraxin 3 Involved in Obesity-Induced Decrease in Arterial Distensibility?

(2011) Asako Miyaki et al.   Journal of Atherosclerosis and Thrombosis

Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET)

(2010) V. Adamsson et al.   JOURNAL OF INTERNAL MEDICINE

Reciprocal Contribution of Pentraxin 3 and C-Reactive Protein to Obesity and Metabolic Syndrome

(2010) Tsuneo Ogawa et al.   Obesity

Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile

(2009) Michela Zanetti et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations

(2009) Kazumi Yamasaki et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk

(2008) Jean-Pierre Després et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors

(2008) L. Alberti et al.   ATHEROSCLEROSIS

Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction

(2008) Monica Salio et al.   CIRCULATION

Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney Disease

(2008) M. E. Suliman et al.   Clinical Journal of the American Society of Nephrology

Pentraxins, humoral innate immunity and tissue injury

(2008) Angelo A Manfredi et al.   CURRENT OPINION IN IMMUNOLOGY

Calorie Restriction Modulates Inactivity-Induced Changes in the Inflammatory Markers C-Reactive Protein and Pentraxin-3

(2008) Alessandra Bosutti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality

(2008) M.E. Suliman et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE